|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S1
|
$35,000
|
$1,400
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S2
|
$5,000
|
$200
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-33
|
$1,795,225
|
$71,809
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Xenobiotic-Metabolizing Enzymes
|
ZIA BC 005562
|
$817,733
|
$408,866
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Xenobiotic Receptors
|
ZIA BC 005708
|
$817,733
|
$327,093
|
Gonzalez, Frank
|
CCR (NCI)
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-14
|
$330,937
|
$3,309
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Workshops On Viral Oncogenesis and Pathogenesis
|
5R13CA095919-10
|
$5,000
|
$750
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Viruses and Cancer
|
2T32CA060395-16
|
$301,776
|
$60,355
|
Courtney, Richard
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Virus-host interactions in hepatocarcinogenesis
|
5P01CA123328-05
|
$1,042,962
|
$1,042,962
|
OU, J.-H. James
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Virus-gene interactions during hepatic carcinogenesis
|
1R21CA158508-01A1
|
$168,019
|
$168,019
|
CHEN, XIN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Viral Vaccine Vectors to Prevent Hepatocellular Carcinoma
|
5R01CA131133-04
|
$229,117
|
$229,117
|
ROBEK, MICHAEL
|
YALE UNIVERSITY
|
|
Viral and Cellular Determinants of Hepatitis B Virus Pathogenesis
|
5R01CA056533-19
|
$411,038
|
$411,038
|
Schneider, Robert
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126-00580
|
$48,591
|
$4,859
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Validation of Therapeutic Target Genes in Human Liver Cancer
|
ZIA BC 011175
|
$359,902
|
$305,916
|
Thorgeirsson, Snorri
|
CCR (NCI)
|
|
Vaccine-Preventable Cancer Behavior Measurement among Southeast Asian Americans
|
5R21CA152078-02
|
$191,624
|
$95,812
|
Lee, Haeok
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S1
|
$74,970
|
$2,999
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S2
|
$139,926
|
$5,597
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-38
|
$4,555,705
|
$182,228
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
ZIA BC 005673
|
$680,406
|
$68,040
|
Keefer, Larry
|
CCR (NCI)
|
|
Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc
|
1K07CA160722-01
|
$170,100
|
$170,100
|
Sanoff, Hanna
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
2P30CA014089-36
|
$6,160,984
|
$246,439
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S1
|
$50,000
|
$2,000
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S2
|
$244,500
|
$9,780
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S3
|
$74,923
|
$2,997
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Urban Health Study
|
ZIA CP005782-10067
|
$121,491
|
$121,491
|
O'Brien, Thomas
|
DCEG (NCI)
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S2
|
$50,000
|
$1,500
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S3
|
$5,694,947
|
$170,848
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
2P30CA134274-04
|
$1,565,163
|
$15,652
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-16S1
|
$74,361
|
$2,974
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
University of California, Irvine Cancer Center Support Grant
|
5P30CA062203-16
|
$1,249,323
|
$49,973
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
UK SPORE in Gastrointestinal Cancer
|
5P20CA150343-03
|
$463,082
|
$277,849
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
Tumor models for the study of inflammation and oncogenesis
|
ZIA BC 010893
|
$248,079
|
$248,078
|
Wiltrout, Robert
|
CCR (NCI)
|
|
Translational Research in Cancer
|
3P30CA056036-12S1
|
$75,000
|
$4,500
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-12
|
$2,947,311
|
$176,839
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Training In Tumor Virology
|
2T32CA115299-06
|
$283,732
|
$56,746
|
Robertson, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
TOR signaling and autophagy in obesity-promoted liver tumorigenesis
|
1R01CA155120-01A1
|
$352,646
|
$352,646
|
KARIN, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Therapeutic/Toxic Effects of Electron Emitting Nuclides
|
5R01CA015523-37
|
$598,440
|
$197,485
|
KASSIS, AMIN
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Therapeutic delivery of anti-miR oligos to hepatocellular cancer
|
1R21CA152969-01A1
|
$199,013
|
$199,013
|
GHOSHAL, KALPANA
|
OHIO STATE UNIVERSITY
|
|
The transcriptional basis of tumor promotion
|
5R01CA104292-08
|
$354,879
|
$354,879
|
LOCKER, JOSEPH
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$1,227,708
|
$49,108
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The role of NKG2D ligands in myeloid cell-NK cell crosstalk in cancer patients
|
5K99CA151412-02
|
$122,419
|
$30,605
|
Crane, Courtney
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
The Role of mTOR Signaling in Hepatocellular Carcinogenesis
|
5U01CA120475-05
|
$287,508
|
$287,508
|
KOZMA, SARA
|
UNIVERSITY OF CINCINNATI
|
|
The role of glutaminase 2, a novel p53 target gene in metabolism, in liver cancer
|
5R01CA143204-02
|
$314,790
|
$314,790
|
Feng, Zhaohui
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
The role of Fas as tumor promoter
|
2R01CA112240-06A1
|
$294,148
|
$147,074
|
PETER, MARCUS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Role of EGF in Human Hepatocellular Transformation
|
5K01CA140861-03
|
$143,848
|
$143,848
|
Fuchs, Bryan
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
The role of cancer stem cells in liver cancer heterogeneity and subtypes
|
ZIA BC 010876
|
$414,026
|
$414,026
|
Wang, Xin Wei
|
CCR (NCI)
|
|
The role of c-met in liver biology
|
ZIA BC 010638
|
$89,976
|
$44,987
|
Thorgeirsson, Snorri
|
CCR (NCI)
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S1
|
$72,130
|
$5,770
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S2
|
$75,000
|
$6,000
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-18
|
$4,829,858
|
$386,389
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
Total relevant funding to Liver Cancer for this search: $66,161,424
|